CINECA IRIS Institutional Research Information System

ABATE, Maria Lorena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.082
EU - Europa 7.906
AS - Asia 6.923
SA - Sud America 297
AF - Africa 250
OC - Oceania 176
Continente sconosciuto - Info sul continente non disponibili 14
Totale 25.648
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.674
CN - Cina 3.713
IT - Italia 1.507
DE - Germania 1.385
SE - Svezia 996
SG - Singapore 952
IE - Irlanda 593
FR - Francia 561
JP - Giappone 433
UA - Ucraina 398
GB - Regno Unito 337
RU - Federazione Russa 312
FI - Finlandia 295
PL - Polonia 274
KR - Corea 266
CA - Canada 265
AT - Austria 263
IN - India 258
TR - Turchia 248
VN - Vietnam 236
BR - Brasile 202
HK - Hong Kong 197
TW - Taiwan 182
AU - Australia 170
DK - Danimarca 164
GR - Grecia 161
ES - Italia 140
ID - Indonesia 132
NL - Olanda 132
MX - Messico 115
EG - Egitto 113
BE - Belgio 73
IR - Iran 49
CH - Svizzera 47
NO - Norvegia 43
RO - Romania 42
PK - Pakistan 39
CZ - Repubblica Ceca 34
PT - Portogallo 34
KE - Kenya 27
MY - Malesia 27
CO - Colombia 25
TH - Thailandia 24
MU - Mauritius 23
SA - Arabia Saudita 22
HU - Ungheria 21
IL - Israele 21
HR - Croazia 18
PH - Filippine 18
UZ - Uzbekistan 16
AR - Argentina 15
CL - Cile 15
EC - Ecuador 15
IQ - Iraq 15
EU - Europa 14
PE - Perù 12
RS - Serbia 12
SI - Slovenia 12
QA - Qatar 11
ZA - Sudafrica 11
BG - Bulgaria 10
NG - Nigeria 10
VE - Venezuela 10
GT - Guatemala 9
ET - Etiopia 8
LU - Lussemburgo 8
MN - Mongolia 8
MO - Macao, regione amministrativa speciale della Cina 8
ZM - Zambia 8
AE - Emirati Arabi Uniti 7
CM - Camerun 7
MA - Marocco 7
BF - Burkina Faso 6
BY - Bielorussia 6
CR - Costa Rica 6
CV - Capo Verde 6
KH - Cambogia 6
NZ - Nuova Zelanda 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
CU - Cuba 5
JO - Giordania 5
CY - Cipro 4
KZ - Kazakistan 4
LV - Lettonia 4
PA - Panama 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
GE - Georgia 3
GH - Ghana 3
LB - Libano 3
LT - Lituania 3
MZ - Mozambico 3
SD - Sudan 3
YE - Yemen 3
AZ - Azerbaigian 2
BD - Bangladesh 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
Totale 25.620
Salva come PNG Salva come JPEG
Città #
Chandler 1.081
Beijing 1.011
Ann Arbor 763
Dublin 585
Fairfield 563
Singapore 563
Ashburn 426
Santa Clara 426
Houston 371
Redwood City 343
Shanghai 334
Wilmington 295
Woodbridge 293
Villeurbanne 279
Dearborn 276
Torino 260
Guangzhou 243
Jacksonville 232
Nyköping 219
Vienna 219
Seattle 217
Pisa 196
Medford 185
Princeton 174
Cambridge 168
Columbus 152
Ottawa 144
Warsaw 144
Fremont 131
Nanjing 121
Dong Ket 117
Hangzhou 110
Tokyo 105
Jakarta 100
Wuhan 100
Taipei 97
Turin 94
New York 92
Chengdu 89
Rome 82
West Jordan 79
Boston 72
Milan 66
Istanbul 62
Sydney 58
Chongqing 57
Boardman 56
Munich 55
Hefei 53
Los Angeles 51
London 50
Brussels 48
Toronto 48
Zhengzhou 46
Helsinki 43
Seoul 43
San Diego 41
Hong Kong 40
Kunming 40
Norwalk 39
Cairo 38
Düsseldorf 38
Pune 38
Jinan 37
Nuremberg 37
Washington 36
Hanoi 35
Shenyang 34
Central 33
Ankara 32
Changsha 32
Tianjin 32
Amsterdam 31
Changchun 31
Duncan 29
Berlin 28
Central District 28
Naples 27
Silver Spring 27
San Mateo 26
Athens 24
Frankfurt am Main 24
Harbin 24
Ho Chi Minh City 24
Delhi 23
Bucharest 22
Phoenix 22
São Paulo 22
Bengaluru 21
Hanover 21
Stavanger 21
Bologna 20
Moscow 20
Xiamen 20
Falls Church 19
Nanning 19
Paris 19
Melbourne 18
Mumbai 18
Nürnberg 18
Totale 13.515
Salva come PNG Salva come JPEG
Nome #
Serum zonulin in patients with inflammatory bowel disease: a pilot study 1.891
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance 1.211
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease 1.114
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection 1.082
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein. 703
Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with Non-Alcoholic Fatty Liver: an external validation study 559
FibroGENE: A gene-based model for staging liver fibrosis 548
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes 478
Chronic hepatitis B therapy: available drugs and treatment guidelines. 379
Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin for hepatocellular carcinoma detection 377
Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-α 375
Outcome of chronic delta hepatitis in Italy: a long-term cohort study. 374
Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II 342
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis 281
Chronic HCV infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, MGUS and B-cell non-Hodgkin lymphoma. 278
IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis 274
Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers. 272
Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers 253
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease 238
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B 215
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease 209
Serum heat shock protein 27 is a new circulating biomarker for hepatocellular carcinoma 194
The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B 193
F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy 186
LIVER DAMAGE CAN BE ASSOCIATED WITH DEREGULATION OF THE DE NOVO LIPOGENESIS PATHWAY IN SUBJECTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 180
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection 178
ABL proteins in Philadelphia-positive acute leukaemias and chronic myelogenous leukaemia blast crises. 175
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single center retrospective study 175
Plasma Selenoprotein P levels are related to adipose tissue insulin resistance, composition of free fatty acids and liver fibrosis in non-diabetic patients with Non Alcoholic Fatty Liver Disease 174
Serum heat shock protein 27 levels in patients with hepatocellular carcinoma. 172
Increased hepatic glucose production and insulin resistance in subjects with non-alcoholic fatty liver disease is associated to increased plasma concentrations of glucogenic amino acids 160
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report 159
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C 156
Alteration in glucose metabolism after an oral glucose load in patients with non-alcoholic fatty liver disease. 155
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C 149
Multiple courses of G-CSF in patients with decompensated cirrosi: consistent mobilization of immature cells ex pressing hepatocyte markers and exploratory clinical evaluation. 148
'e' antigen defective hepatitis B virus and course of chronic infection. 147
Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation 147
CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection. 145
Abnormal insulin sensitivity in-chronic hepatitis C virus (HCV) infection: A link with steatosis? 143
Alteration in glucose metabolism after an oral glucose load and relationship with liver damage in patients with NAFLD. 141
c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. 140
Italian blood donors with anti-HBc and occult hepatitis B virus infection 140
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. 140
Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile. 139
Insulin secretion and decreased glucose clearance are associated with enhanced fibrogenesis and a high risk of disease progression in non-diabetic patients with Non Alcoholic Fatty Liver Disease 138
In non obese NAFLD increased plasma saturated fatty acids and insulin resistance are metabolic signatures of severity of liver disease 138
Increased liver expression of inflammatory mediators is associated with hepatic insulin resistance in lean, non-diabetic patients with chronic hepatitis C. 137
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin 137
Absolute quantification of intrahepatic HBV covalently-closed-circular DNA by droplet digital PCR 137
Effects of IL28B rs12979860 CC Genotype on Metabolic Profile and Sustained Viral Response in Patients with Genotype 1 Chronic Hepatitis C 136
Antibodies against GOR in patients undergoing orthotopic liver trasplantation (OLT) 135
Increased liver expression of inflammatory mediators is associated with hepatic insulin resistance in lean, non-diabetic CHC patients. 134
LIPIDOMICS REVEALS THAT LOW PLASMA UNSATURATED TO SATURATED FAT RATIOS ARE BIOMARKERS OF NAFLD AND LIVER DAMAGE 130
Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort 130
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b. 129
Effects of glucose and fat load on oxidative stress in patients with non-alcoholic fatty liver disease. 128
Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease 128
Validation of surrogate indexes of peripheral and hepatic insulin resistance and evaluation of their utility as non-invasive predictors of histological features in patients with Non-Alcoholic Fatty Liver Disease 127
Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 127
Impact of fat versus glucose load on oxidative stress in non-alcoholic fatty liver disease. 126
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma 126
Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease 124
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases 123
Matabolomic analysis identifies new biomarkers of liver damage in NAFLD 122
The combination of Index of NASH score and liver stiffness improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with NonAlcoholic Fatty Liver Disease. 122
Performance of sequence analysis, INNO-LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations 122
CLINIC EVALUATION OF CIRCULATING MICRORNAS AS POTENTIAL BIOMARKERS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HBV CHRONIC INFECTION 121
Adverse impact of visceral fat on lipid and metabolic profile in fatty liver disease 121
The clinical role of serum epidermal growth factor receptor 3 in hepatitis c virus-infected patients with early hepatocellular carcinoma 120
Incidence of type 2 diabetes mellitus and glucose abnormalities in treated patients with chronic hepatitis C infection: Results of a controlled follow-up study. 119
Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence 118
Bile acids composition modulate insulin resistance in non-diabetic patients with NAFLD 118
IL28Bpolymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients 116
Serum levels of protein induced by vitamin K absence or antagonist-II (PIVKA-II) and alpha-fetoprotein (AFP) at baseline predict overall survival in patients with hepatocellular carcinoma (HCC) 116
Alteration in lipid metabolism after an oral fat load in non-alcoholic fatty liver disease. 116
Oxidative stress-inducible factors promote liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease. 115
DEREGULATION OF DE NOVO LIPOGENESIS CAN BE ASSOCIATED WITH LIVER DAMAGE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 115
ETIOLOGY OF CHRONIC LIVER DISEASES IN THE NORTHWEST OF ITALY, 1998 THROUGH 2014 113
CLINICAL EVALUATION OF CIRCULATING MICRORNAS AS POTENTIAL BIOMARKERS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HBV INFECTION 112
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology 112
Absolute quantification of intrahepatic hepatitis B virus covalently-closed-circular DNA by droplet digital PCR technology 111
Quantitative and qualitative analysis of plasma free fatty acids and their impact on liver damage in NAFLD patients. 109
Diagnostic accuracy of soluble sCD163 for the detection of severe fibrosis in patients with Non-Alcoholic Fatty Liver Disease 109
Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. 109
Incidence of Type 2 diabetes mellitus and glucose abnormalities in treated patients with chronic hepatitis C infection: results of a controlled follow-up study. 108
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C 107
la reinfezione virale nel post -trapianto 107
Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen-negative chronic hepatitis B 106
Angiopoietin-like4 is associated with lipid metabolism and severe fibrosis in non-diabetic patients with non-alcoholic fatty liver disease 106
Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study 106
PNPLA3 gene variants and insulin resistance in patients with genotype-1 chronic hepatitis C 105
Alteration in lipid metabolism after an oral fat load in patients with NAFLD. 105
Serum levels of anti-heat shock protein 27 antibodies in patients with chronic liver disease 105
Liver transplant for viral hepatitis. Recurrence of reinfection 103
Inactive hepatitis B virus carriers: a favourable clinical condition 103
Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitis 103
Cooperative role of thrombopoietin and vascular endothelial growth factor-a in the progression of liver cirrhosis to hepatocellular carcinoma 101
Serological characterization of occult HBV infection in liver donors 100
Increased Pre-Hepatic Insulin Levels Are Directly Related to Nash, Fibrogenesis and Fibrosis in Non Diabetic NAFLD Patients but Not in Type 2 Diabetes 99
Totale 21.779
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.645
article - articoli 0
book - libri 0
conference - conferenze 21.320
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.965
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.071 0 0 0 0 0 0 0 0 335 341 202 193
2020/20213.122 243 308 190 214 310 243 253 164 282 278 254 383
2021/20223.846 180 212 176 384 309 239 341 346 236 446 560 417
2022/20233.931 354 312 164 323 317 768 318 293 397 210 245 230
2023/20243.130 308 342 218 246 216 408 180 307 62 292 227 324
2024/20253.427 185 386 289 413 819 418 218 305 394 0 0 0
Totale 26.395